Abstract
Ephedra (ephérdre du valais in French and Walliser meerträubchen in German) is a small perennial shrub with thin stems. It rarely grows to more than a foot in height, and at first glance, the plant looks very much like a small broom. Different, closely related, species are found in western Europe, southeastern Europe, Asia, and even the New World. Some of the better known species include Ephedra sinica and E. equisentina (collectively known as ma haung) from China, as well as E. geriardiana, E. intermedia, and E. major which grow in India and Pakistan, and countless other members of the family Ephedraceae that grow in Europe and the United States (E. distachya, E. vulgaris). The various species are collectively known as ma huang, even though that name should really be confined to the species grown in China (Namba et al., 1976).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Al-Khalil S, Alkofahi A, et al. Transtorine, a new quinoline alkaloid from Ephedra transitoria. J Nat Prod 1998; 61: 262–3.
Anonymous. Adverse events associated with ephedrine-containing products—Texas, December 1993–September 1995. MMWR Morb Mortal Wkly Rep 1996a; 45: 689–93.
Anonymous. Dietary supplements containing ephedrine alkaloids; proposed rule. 21 CFR 111. Fed Register 1997; 62 (107): 30677–724.
Anonymous. From the Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products—Texas, December 1993–September 1995. JAMA 1996b; 276: 1711–2.
Astrup A, Lundsgaard C. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice. Exp Clin Endocrinol Diabetes 1998; 106 (Suppl 2): 29–34.
Backer R, Tautman D, et al. Fatal ephedrine intoxication. J Forensic Sci 1997; 42: 157–9.
Baselt R, Cravey B. Disposition of toxic drugs and chemicals in man. 3rd edit., Chicago, London: Year Book Medical Publishers, 1989.
Blau JJ. Ephedrine nephrolithiasis associated with chronic ephedrine abuse. J Urol 1998; 160 (3 Pt 1): 825.
Blumenthal M. (ed.) Complete German Commission E monographs, therapeutic guide to herbal medicines. Austin, TX, American Botanical Council, 1998.
Bories H. [Kidney stones]. Infirm Fr 1976; 179: 13–8.
Brater DC, Kaojarern S, et al. Renal excretion of pseudoephedrine. Clin Pharmacol Ther 1980; 28: 690
Bruno A, Nolte KB, et al. Stroke associated with ephedrine use. Neurology 1993; 43: 1313–6.
Chen K, Schmidt C. Ephedrine and related substances. Medicine 1930; 9: 1–94.
Chicharro M, Zapardiel A, et al. Direct determination of ephedrine and norephedrine in human urine by capillary zone electrophoresis. J Chromatogr 1993;8, 622: 103–108.
Chung YT, Hung DZ et al. Intracerebral hemorrhage in a young woman with arteriovenous malformation after taking diet control pills containing phenylpropanolamine: a case report. Chung Hua I Hsueh Tsa Chih (Taipei) 1998; 61: 432–5.
Clarkson P, Thompson H. Drugs and sport. Research findings and limitations. Sports Med 1997; 24: 366–84.
Dawson J, Earnshaw S, et al. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s. J. Accid Emerg Med 1995; 12: 49–51.
Deverall R. Red China’s dirty drug war. The story of opium, heroin, morphine, and philopon traffic, 3rd edit., New York, American Federation of Labor, 1954.
Doyle H, Kargin M. Herbal stimulant containing ephedrine has also caused psychosis. Br Med J 1996; 312: 1441.
ElSohly M, Jones A. Drug testing in the workplace: could a positive test for one of the mandated drugs be for reasons other than illicit use of the drug? J Analyt Toxicol 1995; 19: 450–458.
Flurer CL, Lin LA, et al. Determination of ephedrine compounds in nutritional supplements by cyclodextrin-modified capillary electrophoresis. J Chromatogr B Biomed Appl 1995; 669: 133–9.
Forman HP, Levin S, et al. Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. Pediatrics 1989; 83: 737–41.
Garriott JC, Simmons LM, et al. Five cases of fatal overdose from caffeine-containing “look-alike” drugs. J Analyt Toxicol 1985; 9: 141–3.
Gaultieri J. Cardiomyopathy in a heavy ephedrine abuser. J Toxicol Clin Toxicol 1996; 34: 581–582.
Glick R, Hoying J, et al. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. Neurosurgery 1987; 20: 969–74.
Glidden RS, DiBona FJ. Urinary retention associated with ephedrine. J Pediatr 1977; 90: 1013–4.
Grinspoon L, Hedblom P. The speed culture: amphetamine use and abuse in America. Cambridge, MA, and London, England: Harvard University Press, 1995.
Gruber A, Pope JH. Ephedrine abuse among 36 female weight lifters. Am J Addict 1998; 7: 40.
Hamasaki Y, Kobayashi I, et al. The Chinese herbal medicine, shinpi-to, inhibits IgEmediated leukotriene synthesis in rat basophilic leukemia-2H3 cells. J Ethnopharmacol 1997; 56: 123–31.
Hanzlick R. National Association of Medical Examiners Pediatric Toxicology (PedTox) Registry Report 3. Case submission summary and data for acetaminophen, benzene, carboxyhemoglobin, dextromethorphan, ethanol, phenobarbital, and pseudoephedrine. Am J Forensic Med Pathol 1995; 16: 270–7.
Herridge CF, Brook MF. Ephedrine psychosis. Br Med J 1968; 2: 160.
Holmstedt, B. Historical perspective and future of ethnopharmacology. J Ethnopharmacol 1991; 32: 7–24.
Hurlbut J, Can J, et al. Solid-phase extraction cleanup and liquid chromatography with ultraviolet detection of ephedrine alkaloids in herbal products. JAOAC Int 1998; 81: 1121–7.
Irvine G, Chen L. The environmental impact and adverse health effects of clandestine manufacture of methamphetamine. In NIDA Research Monograph 115, Miller, M. and Kozel, N. (eds.) pp 33–47, 1991.
Ishigooka J, Yoshida Y, et al. Abuse of `BRON“: a Japanese OTC cough suppressant solution containing methylephedrine, codeine, caffeine and chlorpheniramine. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15: 513–21.
Jackson C, Hart A, et al. Fatal intracranial hemorrhage associated with phenylpropanolamine, pentazocine, and tripelenamine overdose. J Emerg Med 1985; 3: 127–32.
Jawad SS, Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998; 36: 73–6.
Johnson DA, Etter HS, et al. Stroke and phenylpropanolamine use [letter]. Lancet 1983; 2: 970.
Jovanovic Z. [Risk factors for stroke in young people]. Srp Arh Celok Lek 1996; 124: 232–5.
Kalix P. The pharmacology of psychoactive alkaloids from ephedra and catha. J Ethnopharmacol 1991; 32: 201–8.
Kanfer I, Dowse R, et al. Pharmacokinetics of oral decongestants. Pharmacotherapy 1993; 13 (6 Pt 2): 116S–128S;
Karch S. The pathology of drug abuse, 2nd edit., Boca Raton, Florida: CRC Press, 1996.
Karch S. Comments on “ma haung toxicity” letter by Dr. Theoharides. J Clin Psychol Pharmacol 1999; 19: 196–199.
Karch S, Green G, et al. Myocardial hypertrophy and coronary artery disease in male cocaine users. J Forensic Sci 1995; 40: 591–595.
Kunsman GW, Jones R, et al. Methylephedrine concentrations in blood and urine specimens. J Analyt Toxicol 1998; 22: 310–3.
Lake C, Rosenberg D, et al. Phenylpropanolamine increases plasma caffeine levels. Clin Pharmacol Ther 1990a; 47: 675–85.
Lake CR, Gallant S, et al. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med 1990b; 89: 195–208.
Lefebvre RA, Surmont F, Bouckaert J, Moerman E. Urinary excretion of ephedrine after nasal application in healthy volunteers. J Pharm Pharmacol 1992; 44: 672–5.
Lermann B, Sten K, et al. Catecholamine facilitated reentrant ventricular tachycardia: uncoupling of adenosine’ s antiadreneregic effects. J Cardiovasc Electrophysiol 1999; 10: 17–26.
Levine B, Jones R, et al. An intoxication involving BRON and verapamil. J Analyt Toxicol 1993; 17: 381–3.
Lietava J. Medicinal plants in a Middle Paleolithic grave Shanidar IV. J Ethnopharmacol 1992; 35: 263–6.
Lindberg AW. [Urinary retention caused by Elsinore pills]. Ugeskr Laeger 1988; 150: 2086–7.
Ling M, Piddlesden SJ, et al. A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement. Clin Exp Immunol 1995; 102: 582–8.
Liu YL, Toubro S, et al. Contribution of beta 3—adrenoceptor activation to ephedrineinduced thermogenesis in humans. Int J Obes Relat Metab Disord 1995; 19: 678–85.
Loizou L, Hamilton J, et al. Intracranial hemorrhage in association with pseudoephedrine overdose. J Neurol Neurosurg Psychiatry 1982; 45: 471–2.
Lyon CC, Turney JH. Pseudoephedrine toxicity in renal failure. Br J Clin Pract 1996; 50: 396–7.
Mariani PJ. Pseudoephedrine-induced hypertensive emergency: treatment with labetalol. Am J Emerg Med 1986; 4: 141–2.
Martin W, Sloan J, et al. Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenemetrazine and methylphenidate in man. Clin Pharmacol Ther 1971; 12: 245–8.
Max B. This and that: the ethnopharmacology of simple phenethylamines, and the question of cocaine and the human heart. Trends Pharm Sci 1991; 12: 329–33.
Nadeau SE. Intracerebral hemorrhage and vasculitis related to ephedrine abuse [letter]. Ann Neurol 1984; 15: 114–5.
Nakahara Y, Kikura R. Hair analysis for drugs of abuse. XIX. Determination of ephedrine and its homologs in rat hair and human hair. J Chromatogr B Biomed Sci Appl 1997; 700: 83–91.
Namba T, Kubo M, et al. Pharmacognostical studies of ephedra plants part I — the comparative histological studies on ephedra rhizomes from Pakistan and Afghanistan and Chinese crude drugs “Ma-Hung-Gen.” Planta Med 1976; 29: 216–25.
Neve KA, Molinoff PB. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors. Am J Cardiol 1986; 57: 17F–22F.
Pomerantz B, O’Rourke R. The Stokes–Adams syndrome. Am J Med 1969; 46: 941–60.
Powell T, Hsu FF, et al. Ma-huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis 1998; 32: 153–9.
Ramsey JJ, Colman RJ, et al. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine. Am J Clin Nutr 1998; 68: 42–51.
Rosene JM, Rosene JA, et al. Decongestant effects on hemodynamics at rest, exercise, and recovery from exercise during 6 degrees of head down tilt. Aviat Space Environ Med 1999; 70: 15–21.
Roxanas MG, Spalding J. Ephedrine abuse psychosis. Med J Aust 1977; 2: 639–40.
Rutstein H. Ingestion of pseudoephedrine. Hypertension and unconsciousness following: report of a case. Arch Otolaryngol 1963; 77: 145–6.
Ryu SJ, Lin SK. Cerebral arteritis associated with oral use of phenylpropanolamine: report of a case. J Formos Med Assoc 1995; 94: 53–55.
Sagara K, Oshima T, et al. A simultaneous determination of norephedrine, pseudoephedrine, ephedrine and methylephedrine in Ephedrae herba and oriental pharmaceutical preparations by ion-pair high-performance liquid chromatography. Chem Pharmacol Bull (Tokyo)1983; 31: 2359–65.
Schafers M, Dutka D, et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res 1998; 82: 57–62.
Schrauwen P, Walder K, et al. Human uncoupling proteins and obesity. Obes Res 1999; 7: 97–1105.
Schweisheimer W. [Kidney stones]. Krankenpflege (Frankf) 1976; 30: 194–5.
Shufman NE, Witztum E, et al. [Ephedrine psychosis]. Harefuah 1994;127: 166–8, 215.
Sidney K, Lefcoe NM. The effects of ephedrine on the physiological and psychological responses to submaximal and maximal exercise in man. Med Sci Sports 1977; 9: 95–99.
Smith D, Perry P. The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents. Ann Pharmacother 1992; 26: 653–9.
Stoessl AJ, Young GB, et al. Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergics. Stroke 1985; 16: 734–6.
Strand OA, Lund-Tonnesen S, et al. [Cerebral hemorrhage associated with phenylpropanolamine]. Tidsskr Nor Laegeforen 1991; 111: 1490–2.
Suwanwela C, Poshyachinda V. Drug abuse in Asia. Bull Narc 1986; 38: 41–53.
Sweeney S, Kelly R, et al. Amphetamines in hair by enzyme-linked immunosorbent assay. J Analyt Toxicol. 1998; 22: 418–24.
Takahashi T, Minakami H, et al. Hyperamylasemia in response to ritodrine or ephedrine administered to pregnant women. J Am Coll Surg 1997; 184: 31–6.
Takayasu T, Ohshima T, et al. False identification of urinary ephedrine as methamphetamine by gas chromatography/mass spectrometry with a DB-17 column. Nippon Hoigaku Zasshi 1997; 51: 235–40.
Tapia J. [Cerebral hemorrhage associated with the use of phenylpropanolamine. Clinical cases]. Rev Med Chil 1996; 124: 1499–503.
Taylor E, Oertli E, et al. Accuracy of five on-site immunoassay drugs-of-abuse testing devices. J Analyt Toxicol 1999; 23: 119–24.
Tekol Y, Tercan E, et al. Ephedrine enhances analgesic effect of morphine. Acta Anaesthesiol Scand 1994; 38: 396–7.
Theoharides T. Reply to Comments by Dr. Karch. J Clin Psychol Pharmacol 1999; 19: 198–9.
Thomas SH, Clark KL, et al. A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies. Br J Clin Pharmacol 1991; 32: 705–11.
To L, Sangster J, et al. Ephedrine-induced cardiomyopathy. Med J Aust 1980; 2: 35–6.
Tokunaga I, Takeichi S, et al. Electroencephalographical analysis of acute drug intoxication—SS Bron solution-W. Arukoru Kenkyuto Yakubutsu Ison 1989; 24: 471–9.
Upton R. Pharmacokinetic interactions between theophylline and other medication (Part I). Clin Pharmacokinet 1991; 20: 66–80.
Vanakoski J, Seppala T. Heat exposure and drugs. A review of the effects of hyperthermia on pharmacokinetics. Clin Pharmacokinet 1998; 34: 311–22.
Waluga M, Janusz M, et al. Cardiovascular effects of ephedrine, caffeine, and yohimbine measured by thoracic electrical bioimpedance in obese women. Clin Physiol 1998; 18: 69–76.
Webb AA, Shipton EA. Re-evaluation of i.m. ephedrine as prophylaxis against hypotension associated with spinal anaesthesia for Caesarean section. Can J Anaesth 1998; 45: 367–9.
Weesner K, Denison M, et al. Cardiac arrhythmias in an adolescent following ingestion of an over-the-counter stimulant. Clin Pediatr 1982; 21: 700–1.
Weiner I, Tilkian A, et al. Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: temporal relationship to pseudoephedrine ingestion. Cath Cardiovas Diag 1990; 20: 51–3.
White LM, Gardner SF, et al. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol 1997; 37: 116–22.
Whitehouse AM, Duncan JM. Ephedrine psychosis rediscovered. Br J Psychiatry 1987; 50: 258–61.
Wilkinson G, Beckett A. Absorption, metabolism, and excretion of the ephedrines in man. II. Pharmacokinetics. J Pharm Sci 1968; 57: 1933–8.
Wooten MR, Khangure MS, et al. Intracerebral hemorrhage and vasculitis related to ephedrine abuse. Ann Neurol 1983; 13: 337–40.
Yap JC, Critchley LA, et al. A comparison of three fluid-vasopressor regimens used to prevent hypotension during subarachnoid anaesthesia in the elderly. Anaesth Intensive Care 1998; 26: 497–502.
Yin PA. Ephedrine-induced intracerebral hemorrhage and central nervous system vasculitis. Stroke 1990; 21: 1641.
Zhang J, Tian Z, et al. [Quality evaluation of twelve species of Chinese Ephedra]. Yao Hsueh Hsueh Pao 1989; 24: 865–871.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Karch, S.B. (2000). Ma Huang and the Ephedra Alkaloids . In: Cupp, M.J. (eds) Toxicology and Clinical Pharmacology of Herbal Products. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-020-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-020-9_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-190-5
Online ISBN: 978-1-59259-020-9
eBook Packages: Springer Book Archive